Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review

  1. Gómez-Arias, P.J.
  2. Gómez-García, F.
  3. Hernández-Parada, J.
  4. Montilla-López, A.M.
  5. Ruano, J.
  6. Parra-Peralbo, E.
Revue:
Dermatology and Therapy

ISSN: 2190-9172,  2193-8210

Année de publication: 2021

Volumen: 11

Número: 3

Pages: 733-750

Type: Révision

DOI: 10.1007/S13555-021-00517-9 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus